跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pantovex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pantovex
Approved
STANDARD
Pantovex
Hiral Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
731d388610b2f6c0
Company
Hiral Labs Limited
Type
Standard
Approval Details
Approval Id
731d388610b2f6c0
Drug Approval Philippines Name
Pantovex
Product Name
Pantovex
Registration Number
DRP-8185-02
Brand Name
Pantovex
Generic Name
Pantoprazole (as sodium)
Dosage Form
Delayed-Release Tablet
Dosage Strength
40 mg
Manufacturer
Hiral Labs Limited
Importer
Aglobal Care, Inc.
Distributor
Sannovex Pharmaceutical Distributor
Issuance Date
24 September 2024
Expiry Date
01 December 2025
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
731d388610b2f6c0
Type
Standard
Back to Philippines FDA Approvals